Madison Avenue Partners’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105M | Hold |
9,511,150
| – | – | 7% | 6 |
|
|
2025
Q1 | $84.9M | Hold |
9,511,150
| – | – | 7.21% | 5 |
|
|
2024
Q4 | $89.5M | Hold |
9,511,150
| – | – | 9.48% | 4 |
|
|
2024
Q3 | $76.7M | Buy |
9,511,150
+999,800
| +12% | +$8.06M | 7.11% | 6 |
|
|
2024
Q2 | $72.2M | Buy |
8,511,350
+1,499,124
| +21% | +$12.7M | 9.12% | 4 |
|
|
2024
Q1 | $62.9M | Hold |
7,012,226
| – | – | 10.15% | 3 |
|
|
2023
Q4 | $78.8M | Hold |
7,012,226
| – | – | 11.13% | 3 |
|
|
2023
Q3 | $60.5M | Hold |
7,012,226
| – | – | 8.59% | 4 |
|
|
2023
Q2 | $72.6M | Hold |
7,012,226
| – | – | 15.83% | 3 |
|
|
2023
Q1 | $76.1M | Hold |
7,012,226
| – | – | 16.36% | 2 |
|
|
2022
Q4 | $78.7M | Hold |
7,012,226
| – | – | 13.94% | 2 |
|
|
2022
Q3 | $71.1M | Sell |
7,012,226
-257,358
| -4% | -$2.61M | 15.25% | 2 |
|
|
2022
Q2 | $65.9M | Hold |
7,269,584
| – | – | 13.47% | 2 |
|
|
2022
Q1 | $69.5M | Buy |
7,269,584
+621,559
| +9% | +$5.94M | 12.98% | 2 |
|
|
2021
Q4 | $73.5M | Buy |
6,648,025
+1,718,602
| +35% | +$19M | 15.9% | 2 |
|
|
2021
Q3 | $36.5M | Buy |
+4,929,423
| New | +$36.5M | 8.08% | 7 |
|